Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dysmenorrhea | 22 | 2025 | 56 | 9.350 |
Why?
|
| Pelvic Pain | 13 | 2024 | 86 | 3.960 |
Why?
|
| Chronic Pain | 9 | 2023 | 171 | 3.350 |
Why?
|
| Cystitis, Interstitial | 7 | 2021 | 54 | 3.070 |
Why?
|
| Naproxen | 4 | 2024 | 15 | 2.430 |
Why?
|
| Pain Measurement | 13 | 2025 | 360 | 1.910 |
Why?
|
| Urinary Bladder | 8 | 2025 | 250 | 1.460 |
Why?
|
| Dyspareunia | 3 | 2025 | 22 | 1.300 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2023 | 46 | 1.200 |
Why?
|
| Pain Threshold | 9 | 2024 | 61 | 1.190 |
Why?
|
| Uterus | 4 | 2021 | 222 | 1.160 |
Why?
|
| Visceral Pain | 2 | 2018 | 6 | 1.150 |
Why?
|
| Raphe Nuclei | 4 | 2012 | 37 | 1.050 |
Why?
|
| Endometrium | 1 | 2024 | 50 | 0.870 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2024 | 246 | 0.860 |
Why?
|
| Hyperalgesia | 3 | 2021 | 22 | 0.840 |
Why?
|
| Oxytocin | 2 | 2020 | 74 | 0.760 |
Why?
|
| Female | 30 | 2025 | 47893 | 0.740 |
Why?
|
| Morphine | 3 | 2012 | 130 | 0.740 |
Why?
|
| Dysuria | 1 | 2019 | 8 | 0.670 |
Why?
|
| Muscle Contraction | 2 | 2018 | 287 | 0.640 |
Why?
|
| Constipation | 1 | 2019 | 69 | 0.620 |
Why?
|
| Sleep | 5 | 2012 | 461 | 0.620 |
Why?
|
| Oxygen | 1 | 2024 | 763 | 0.610 |
Why?
|
| Pain, Referred | 1 | 2018 | 2 | 0.600 |
Why?
|
| Young Adult | 12 | 2025 | 6624 | 0.600 |
Why?
|
| Pelvic Floor | 2 | 2017 | 86 | 0.590 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 20 | 0.590 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2018 | 5 | 0.590 |
Why?
|
| Muscle Cramp | 1 | 2018 | 5 | 0.590 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2017 | 18 | 0.560 |
Why?
|
| Uterine Contraction | 1 | 2017 | 8 | 0.560 |
Why?
|
| Platelet Activating Factor | 1 | 2017 | 53 | 0.550 |
Why?
|
| Pain Perception | 2 | 2018 | 19 | 0.540 |
Why?
|
| Drug Resistance | 1 | 2017 | 235 | 0.530 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1774 | 0.530 |
Why?
|
| Adult | 15 | 2025 | 27532 | 0.520 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 137 | 0.510 |
Why?
|
| Nociceptive Pain | 1 | 2015 | 3 | 0.490 |
Why?
|
| Humans | 30 | 2025 | 92337 | 0.490 |
Why?
|
| Electromyography | 6 | 2018 | 191 | 0.460 |
Why?
|
| Menstruation | 3 | 2024 | 35 | 0.420 |
Why?
|
| Analgesics, Opioid | 4 | 2021 | 472 | 0.420 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 3 | 2009 | 22 | 0.410 |
Why?
|
| Hypoxia | 1 | 2017 | 672 | 0.380 |
Why?
|
| Case-Control Studies | 4 | 2024 | 1902 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3509 | 0.370 |
Why?
|
| Surveys and Questionnaires | 6 | 2025 | 2729 | 0.370 |
Why?
|
| Electroencephalography | 5 | 2010 | 771 | 0.350 |
Why?
|
| Prospective Studies | 5 | 2025 | 4468 | 0.330 |
Why?
|
| Fear | 2 | 2007 | 82 | 0.320 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 109 | 0.320 |
Why?
|
| Biological Clocks | 1 | 2010 | 75 | 0.310 |
Why?
|
| Homeostasis | 3 | 2009 | 450 | 0.310 |
Why?
|
| Cardiovascular System | 1 | 2009 | 64 | 0.310 |
Why?
|
| Respiratory System | 1 | 2009 | 119 | 0.300 |
Why?
|
| Thalamus | 1 | 2010 | 133 | 0.300 |
Why?
|
| Wakefulness | 4 | 2012 | 136 | 0.290 |
Why?
|
| Neurons | 4 | 2012 | 1596 | 0.290 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 593 | 0.280 |
Why?
|
| Nociceptors | 1 | 2007 | 30 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 7 | 2012 | 3360 | 0.260 |
Why?
|
| Uterine Artery | 1 | 2024 | 6 | 0.220 |
Why?
|
| Menarche | 1 | 2024 | 30 | 0.220 |
Why?
|
| Mice | 9 | 2017 | 12110 | 0.220 |
Why?
|
| Ultrasonography, Doppler | 1 | 2024 | 83 | 0.210 |
Why?
|
| Myometrium | 1 | 2024 | 51 | 0.210 |
Why?
|
| Animals | 11 | 2021 | 28003 | 0.200 |
Why?
|
| Analgesics | 2 | 2020 | 122 | 0.180 |
Why?
|
| Hot Temperature | 3 | 2012 | 213 | 0.180 |
Why?
|
| Risk Factors | 3 | 2025 | 5704 | 0.170 |
Why?
|
| Anxiety | 2 | 2025 | 324 | 0.170 |
Why?
|
| Rats | 4 | 2012 | 4067 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1919 | 0.170 |
Why?
|
| Comorbidity | 2 | 2022 | 987 | 0.160 |
Why?
|
| Cohort Studies | 2 | 2024 | 2978 | 0.160 |
Why?
|
| Heart Rate | 3 | 2019 | 502 | 0.160 |
Why?
|
| Depression | 2 | 2025 | 526 | 0.150 |
Why?
|
| Microinjections | 2 | 2009 | 71 | 0.150 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 66 | 0.150 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 165 | 0.150 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2018 | 39 | 0.150 |
Why?
|
| Parasympatholytics | 1 | 2017 | 19 | 0.140 |
Why?
|
| Receptors, Oxytocin | 1 | 2017 | 10 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2020 | 900 | 0.140 |
Why?
|
| Sildenafil Citrate | 1 | 2017 | 23 | 0.140 |
Why?
|
| Denervation | 1 | 2017 | 24 | 0.140 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2017 | 18 | 0.140 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 30 | 0.140 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2017 | 28 | 0.140 |
Why?
|
| Dinoprost | 1 | 2017 | 26 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 259 | 0.140 |
Why?
|
| Sleep, REM | 3 | 2007 | 51 | 0.140 |
Why?
|
| Ablation Techniques | 1 | 2017 | 38 | 0.140 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 42 | 0.140 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 121 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2009 | 1235 | 0.140 |
Why?
|
| Diuresis | 1 | 2017 | 26 | 0.140 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 105 | 0.140 |
Why?
|
| Physical Examination | 2 | 2015 | 151 | 0.140 |
Why?
|
| Complementary Therapies | 1 | 2017 | 55 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 145 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1756 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 165 | 0.130 |
Why?
|
| Seasons | 1 | 2018 | 241 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 305 | 0.130 |
Why?
|
| Pressure | 1 | 2017 | 169 | 0.130 |
Why?
|
| Perfusion | 1 | 2017 | 261 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2017 | 147 | 0.120 |
Why?
|
| Palpation | 1 | 2015 | 18 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2017 | 595 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 188 | 0.120 |
Why?
|
| Pelvic Floor Disorders | 1 | 2015 | 56 | 0.120 |
Why?
|
| Phenotype | 2 | 2019 | 2498 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 996 | 0.110 |
Why?
|
| Adolescent | 3 | 2024 | 9504 | 0.100 |
Why?
|
| Sleep Deprivation | 3 | 2010 | 138 | 0.100 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 82 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2087 | 0.100 |
Why?
|
| Pain | 2 | 2021 | 406 | 0.090 |
Why?
|
| Male | 8 | 2012 | 43925 | 0.090 |
Why?
|
| Neuralgia | 1 | 2011 | 33 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2013 | 708 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 692 | 0.090 |
Why?
|
| Analgesia | 1 | 2011 | 60 | 0.090 |
Why?
|
| Anesthesia | 1 | 2012 | 167 | 0.090 |
Why?
|
| Physical Stimulation | 2 | 2007 | 74 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2010 | 2 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2010 | 26 | 0.080 |
Why?
|
| Sleep Stages | 1 | 2010 | 47 | 0.080 |
Why?
|
| Electrophysiology | 2 | 2007 | 402 | 0.080 |
Why?
|
| Arrhythmia, Sinus | 1 | 2009 | 7 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2019 | 909 | 0.080 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 66 | 0.080 |
Why?
|
| Bradycardia | 1 | 2009 | 42 | 0.080 |
Why?
|
| Motor Activity | 2 | 2009 | 330 | 0.080 |
Why?
|
| Theta Rhythm | 2 | 2007 | 36 | 0.080 |
Why?
|
| Hippocampus | 2 | 2006 | 435 | 0.080 |
Why?
|
| Action Potentials | 1 | 2012 | 604 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2010 | 325 | 0.070 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 148 | 0.070 |
Why?
|
| Receptors, Opioid, mu | 1 | 2007 | 45 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 195 | 0.070 |
Why?
|
| Electroshock | 1 | 2007 | 17 | 0.070 |
Why?
|
| Delta Rhythm | 1 | 2007 | 19 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 309 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2009 | 183 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2007 | 103 | 0.070 |
Why?
|
| Polysomnography | 1 | 2007 | 151 | 0.070 |
Why?
|
| Conditioning, Classical | 1 | 2006 | 37 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 1589 | 0.060 |
Why?
|
| Association Learning | 1 | 2006 | 37 | 0.060 |
Why?
|
| Gene Expression | 1 | 2010 | 1312 | 0.060 |
Why?
|
| Amygdala | 1 | 2006 | 87 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 306 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2007 | 507 | 0.060 |
Why?
|
| Memory | 1 | 2007 | 223 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 2004 | 99 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 68 | 0.050 |
Why?
|
| Skin | 1 | 2006 | 594 | 0.050 |
Why?
|
| Arousal | 1 | 2003 | 171 | 0.050 |
Why?
|
| Middle Aged | 2 | 2021 | 27030 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2448 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2794 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 120 | 0.040 |
Why?
|
| Urination | 1 | 2019 | 40 | 0.040 |
Why?
|
| Kindling, Neurologic | 1 | 1998 | 2 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 1998 | 32 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 800 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1294 | 0.030 |
Why?
|
| Epilepsy | 1 | 1998 | 430 | 0.030 |
Why?
|
| Nerve Block | 1 | 2011 | 51 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7334 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 135 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2009 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 693 | 0.020 |
Why?
|
| Posterior Horn Cells | 1 | 2006 | 9 | 0.020 |
Why?
|
| Muscimol | 1 | 2006 | 19 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2006 | 20 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 9703 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2006 | 87 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2006 | 19 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 52 | 0.020 |
Why?
|
| Rectum | 1 | 2006 | 149 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2006 | 371 | 0.020 |
Why?
|
| Serotonin | 1 | 2006 | 219 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 238 | 0.010 |
Why?
|
| Cues | 1 | 2006 | 177 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2004 | 6 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2004 | 7 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2004 | 33 | 0.010 |
Why?
|
| Epinephrine | 1 | 2004 | 89 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2004 | 173 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2006 | 385 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 231 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1477 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 1863 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1998 | 49 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1998 | 99 | 0.010 |
Why?
|
| Models, Neurological | 1 | 1998 | 425 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1998 | 1111 | 0.010 |
Why?
|